|
STAM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.498700E-03 |
| Normal-vs-Stage3 |
1.47369894065719E-11 |
| Normal-vs-Stage4 |
5.97629945531253E-10 |
| Stage1-vs-Stage2 |
2.543900E-03 |
| Stage1-vs-Stage3 |
6.903800E-01 |
| Stage1-vs-Stage4 |
2.253000E-01 |
| Stage2-vs-Stage3 |
2.286200E-02 |
| Stage2-vs-Stage4 |
7.042600E-04 |
| Stage3-vs-Stage4 |
1.350010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.119010E-03 |
| Normal-vs-Asian |
1.79209999950913E-07 |
| Caucasian-vs-AfricanAmerican |
9.827600E-01 |
| Caucasian-vs-Asian |
8.667800E-01 |
| AfricanAmerican-vs-Asian |
9.278000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.09119438116568E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.753790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.19980000379272E-08 |
| Normal-vs-Age(81-100Yrs) |
8.133600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.553700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.235700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.664800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.506200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.826400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.671400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.758000E-02 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
4.148000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.29030000017849E-08 |
| Tall-VS-Other |
4.129900E-02 |
| Tall-VS-Normal |
1.25360000158281E-09 |
| Follicular-VS-Other |
4.381900E-02 |
| Follicular-VS-Normal |
8.878000E-02 |
| Other-VS-Normal |
1.705650E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58539847916472E-11 |
| Normal-vs-N1 |
3.82729999914844E-08 |
| N0-vs-N1 |
4.239400E-03 |
|
|
